section name header

Indications ⬇

REMS


Unlabeled Use:

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Seen primarily as manifestations of toxicity (hypercalcemia)

CV: arrhythmias, hypertension

Derm: pruritus

EENT: conjunctivitis, photophobia, rhinorrhea

F and E: hypercalcemia, polydipsia

GI: ↑liver enzymes, abdominal pain, anorexia, constipation, dry mouth, nausea, PANCREATITIS, vomiting

GU: ↓libido, albuminuria, azotemia, nocturia, polyuria

Local: pain at injection site

Metab: hyperthermia, weight loss

MS: bone pain, metastatic calcification, muscle pain

Neuro: dysgeusia, headache, somnolence, weakness

Misc: hypersensitivity reactions

Interactions ⬆ ⬇

Drug-drug:

Drug-Food:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Hypocalcemia Associated with Hypoparathyroidism or Pseudohypoparathyroidism

Secondary Hyperparathyroidism in Chronic Kidney Disease

Rickets

US Brand Names ⬆ ⬇

Calcijex, Rocaltrol

Action ⬆ ⬇

  • Calcitriol is the active form of vitamin D.
  • Promotes the absorption of calcium and decreases parathyroid hormone concentrations.
Therapeutic effects:
  • Treatment and prevention of deficiency states, particularly bone manifestations.
  • Improved calcium and phosphorous homeostasis in patients with chronic kidney disease.

Classifications ⬆ ⬇

Therapeutic Classification: vitamins

Pharmacologic Classification: fat soluble vitamins

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability; Well absorbed following oral administration.

Distribution: Unknown.

Protein Binding: 99.9%.

Metabolism/Excretion: Undergoes enterohepatic recycling and is excreted mostly in bile.

Half-Life: Normal renal function: 5–8 hr; Chronic renal failure: 16–22 hr.

Time/Action Profile ⬆ ⬇

(effects on serum calcium)

ROUTEONSETPEAKDURATION
PO2–6 hr2–6 hr3–5 days

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

kal-si-TRYE-ole

Code ⬆

NDC Code